CTOs on the Move

Mercy Flight Central Inc

www.mercyflightcentral.org

 
Mercy Flight Central Inc is a Canandaigua, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

TropiClean

Tropiclean Pet Products, a division of Cosmos Corporation, has been providing pet owners and professionals with innovative solutions in the pet care category for over 20 years.

Elite Physical Therapy

Elite Physical Therapy believes our first responsibility is to our patients, who will always be treated with courtesy, dignity and respect. We will customize your treatment in order to meet your individual needs as a patient. Our staff works diligently to provide patients with the highest quality of care, while continuing to educate ourselves and our patients with improvements in the field of healthcare. Our goal is to provide these services based on a firm foundation of integrity, honesty, dedication and mutual respect.

EmCare Holdings

EmCare Holdings Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. EmCare Holdings Inc. is based in Dallas, TX. You can find more information on EmCare Holdings Inc. at www.emcare.com

Extend Fertility

Extend Fertility is the first service in the U.S. focused exclusively on women who want to proactively preserve their fertility options.

PharmaBlock Sciences

PharmaBlock Sciences (Nanjing), Inc. is a leading innovative chemistry products and services provider throughout the pharmaceutical R&D process. Its core businesses include: a catalog of specially designed scaffolds and building blocks; custom synthesis; process development; manufacturing of key intermediates and RSMs; and FTE services. The company was listed on Shenzhen Exchange Stock in China on November 10, 2017. PharmaBlock has rapidly gained recognition for its outstanding capability in the design, synthesis, and supply of lab scale building blocks. Building on that success, the company acquired Shandong Diai Biotechnology Co., Ltd. as its pilot plant and manufacturing site in 2016, and is providing scale-up synthesis and manufacturing of key intermediates/RSMs. PharmaBlock is now committed to a more comprehensive and long-term service to valued customers.